West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
415.65
-2.15 (-0.51%)
Nov 17, 2026, 10:44 AM EST - Market open

WST Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
464.1791.3484.6853.9894.3762.6
Cash & Short-Term Investments
464.1791.3484.6853.9894.3762.6
Cash Growth
-26.16%63.29%-43.25%-4.52%17.27%23.90%
Receivables
763.3586.3575.8533.5523.7503.6
Inventory
464.7443.9377434.7414.8378.4
Other Current Assets
124.4156.7100.7114.386.797.4
Total Current Assets
1,8171,9781,5381,9361,9201,742
Property, Plant & Equipment
1,8081,8781,7161,5131,2631,127
Long-Term Investments
215.8212.3202.1210204.9207.7
Goodwill
108.7109.9106108.5107.3109.9
Other Intangible Assets
6.27.710.815.118.423
Long-Term Deferred Tax Assets
60.238.42625.765.648.5
Other Long-Term Assets
45.445.444.621.338.455.9
Total Assets
4,0614,2703,6433,8303,6173,314

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
249.4253.7239.3242.4215.4232.2
Accrued Expenses
162.9214.6138161.3145.8186.1
Current Portion of Long-Term Debt
---1342.244.2
Current Portion of Leases
20.924.218.817.7169.3
Current Income Taxes Payable
56.228.131.516.624.826.3
Current Unearned Revenue
-51.949.641.757.348.7
Other Current Liabilities
154.982.473.258.157.547.3
Total Current Liabilities
644.3654.9550.4671.8519594.1
Long-Term Debt
202.9202.8202.672.8206.7208.8
Long-Term Leases
90.199.283.984.59363
Long-Term Unearned Revenue
-1.83.612.210.9-
Pension & Post-Retirement Benefits
28.62928.229.628.240.5
Long-Term Deferred Tax Liabilities
232320.512.714.34.9
Other Long-Term Liabilities
103.683.371.964.959.867.1
Total Liabilities
1,0931,094961.1948.5931.9978.4

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
18.818.818.818.818.818.8
Additional Paid-In Capital
--22.1120.2232.2249
Retained Earnings
4,8174,3753,9573,5232,9882,457
Treasury Stock
-1,730-1,112-1,057-637.6-370.9-229.5
Comprehensive Income & Other
-137-105.5-258.1-143.8-183-159.6
Shareholders' Equity
2,9683,1762,6822,8812,6852,335
Total Liabilities & Equity
4,0614,2703,6433,8303,6173,314

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
313.9326.2305.3309317.9325.3
Net Cash (Debt)
150.2465.1179.3544.9576.4437.3
Net Cash Growth
-53.86%159.40%-67.09%-5.46%31.81%53.87%
Net Cash Per Share
2.096.402.437.247.605.73
Filing Date Shares Outstanding
69.6672.0272.373.374.1474.28
Total Common Shares Outstanding
69.87272.373.574.174.2
Working Capital
1,1721,323987.71,2651,4011,148
Book Value Per Share
42.5244.1137.1039.2036.2331.47
Tangible Book Value
2,8533,0582,5662,7572,5592,203
Tangible Book Value Per Share
40.8842.4835.4837.5234.5429.68
Land
-29.227.933.72929.3
Buildings
-1,181916.1771.5663.6644.8
Machinery
-1,7571,6311,5181,3881,298
Construction In Progress
-256.7410.8415.2305.9242.7
SEC Filings: 10-K · 10-Q